MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Is cathepsin D a good target for therapy in Tau-related conditions?

    G. Kovacs, A. Jafrani, G. Puska, I. Martinez-Valbuena, S. Lee, S. Knott, A. Karakani, S. Tanikawa, A. Lang, S. Forrest (Toronto, Canada)

    Objective: To study the involvement of cathepsin D in the pathogenesis of Tau-related conditions. Background: The endo-lysosomal system (ELS) is central in processing of neurodegenerative…
  • 2024 International Congress

    Identification of underlying Lewy body pathology in primary tauopathies by α-synuclein seed amplification assay

    L. Concha-Marambio, C. Farris, S. Weber, Y. Ma, T. Tropea, D. Irwin, A. Siderowf, B. Mollenhauer (san diego, USA)

    Objective: To determine intravitam prevalence of α-synuclein (αSyn) pathology in primary tauopathies, such as PSP and CBS, by αSyn seed amplification assay (synSAA) Background: Neuropathological…
  • 2024 International Congress

    Early Syndromes and Clinicopathologic Progression in Progressive Supranuclear Palsy

    D. Ono, H. Sekiya, N. Ghayal, A. Maier, S. Roemer, D. Dickson (Jacksonville, USA)

    Objective: We aimed to characterize early clinical features of progressive supranuclear palsy (PSP) that might correlate with clinical course and neuropathologic findings. Background: Progressive supranuclear…
  • 2024 International Congress

    18F-Florzolotau PET uncovers the Co-pathological Heterogeneity of Tau Protein in Dementia with Lewy Bodies

    G. Tang, XY. Li, FT. Liu, J. Wang (Shanghai, China)

    Objective: We attempted to reveal the topographical deposition patterns of tau proteins in the living brains of patients with DLB in vivo by virtue of…
  • 2024 International Congress

    Passive smartphone speech monitoring in isolated rapid eye movement sleep behaviour disorder

    V. Illner, M. Novotny, T. Kouba, T. Tykalova, M. Simek, P. Sovka, J. Svihlik, E. Ruzicka, K. Sonka, P. Dusek, J. Rusz (Prague 6, Czech Republic)

    Objective: We aimed to design and test the sensitivity of a fully-automated and noise-resistant smartphone-based system that can unobtrusively screen for prodromal parkinsonian speech disorder…
  • 2024 International Congress

    Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson’s Disease

    L. Collins-Praino, A. Mcnamara, B. Ellul, I. Baetu, S. Lau, M. Jenkinson (Adelaide, Australia)

    Objective: To assess whether including measurements of neuroimaging and biofluid-based biomarkers improves predictive ability of models of motor and non-motor progression up to 5-year follow-up…
  • 2024 International Congress

    Vestibular impairment, turning direction and turn progression in Parkinson’s disease

    C. Pongmala, M. van Emde-Boas, P. Kanel, N. Bohnen (Ann Arbor, USA)

    Objective: To explore the correlation between the Romberg test condition 4 and turn progression in most affected and least affected body side directions in people…
  • 2024 International Congress

    Risk Factors Of Parkinson’s Disease A Case-Control Study In Tunisian Patients

    S. Sellami, N. Farhat, KS. Moalla, N. Bouattour, S. Daoued, S. Sakka, M. Damak, C. Mhiri (Sfax, Tunisia)

    Objective: To investigate the role of family, environmental and professional factors in Parkinson's disease (PD) development. Background: Parkinson's disease (PD) is a neurological disorder with…
  • 2024 International Congress

    Exploring Retrospectively the Predisposing Factors of Sleep Disorders in Parkinson’s Disease.

    SF. Arechavala Lopez, I. Fuentes Calvo, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (CDMX, Mexico)

    Objective: Identify the predisposing or exacerbating factors of sleep disorders in Parkinson's disease, and examine their association with levodopa treatment. Background: Parkinson's disease (PD) is…
  • 2024 International Congress

    Atypical Parkinsonism Secondary to Recurrent Deep Vein Thrombosis with Associated Intracranial Dural Fistula

    C. Gómez López-de-San-Román, DM. Cerdán Santacruz, M. Capra, L. Caballero Sánchez, I. Bermejo Casado, A. Castrillo Sanz, A. Mendoza Rodríguez, G. Suárez Fernández, P. Guerrero Becerra, M. Vargas Cobos, C. Tabernero Garcia (Segovia, Spain)

    Objective:  This report aims to present a case of atypical parkinsonism that is secondary to recurrent deep vein thrombosis with associated intracranial dural fistula. Background:…
  • « Previous Page
  • 1
  • …
  • 157
  • 158
  • 159
  • 160
  • 161
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley